BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 28, 2020
View Archived Issues
T-cell aging induces broad senescence
Read More
ALK is a candidate thinness gene
Read More
In vivo data support human trials of CRISPR/Cas9-mediated homology-directed repair treatment for SCD
Read More
ExoFlo stem cell-derived exosomes show promise for severe COVID-19 disease
Read More
FDA grants approval to artesunate for injection in severe malaria
Read More
Gilead identifies new MAP4K1 inhibitors
Read More
TGF-beta receptor type-1 inhibitors discovered at Medshine Discovery
Read More
Dana-Farber Cancer Institute patents EP300 degraders
Read More
Merck & Co. identifies new Nav1.8 channel blockers
Read More
ViiV Healthcare presents HIV-1 capsid protein p24 assembly inhibitors
Read More
Researchers unveil PAR-1 as being involved in ALS pathogenesis
Read More
gnomAD identifies rare loss-of-function variants
Read More
FDA approves VESIcare LS oral suspension for neurogenic detrusor overactivity in pediatric patients
Read More
FDA clears Expression Therapeutics' IND for phase I trial of gene therapy for hemophilia A
Read More
Zeposia receives European approval for the treatment of adult patients with RRMS
Read More
Positive topline data from phase II BRIGHT trial of Zygel in autism spectrum disorder
Read More
Positive results from compassionate use study of Organicell Flow in severe COVID-19
Read More
First-in-human data for B-VEC in patients with recessive dystrophic epidermolysis bullosa
Read More
Corin overcomes BRAF inhibitor resistance in vivo
Read More
DMC clears clinical study of TJM-2 in severe COVID-19 to advance into part 2
Read More
FDA clears initiation of phase II study of PB-1046 for hospitalized patients with COVID-19
Read More
New phase III trial to evaluate Actemra with remdesivir for severe COVID-19 pneumonia
Read More
Atriva plans to study ATR-002 in phase II trial for COVID-19
Read More
New arm of I-SPY COVID trial to evaluate razuprotafib for COVID-19-related ARDS
Read More
